Abstract
Tumour necrosis factor-alpha (TNF-alpha) reduced the interstitial fluid pressure (IFP) to 54-64% (P < 0.05) and the mean arterial blood pressure (MABP) to 70% (P < 0.01) of control values after 5 h in three human melanoma tumour lines transplanted to nude mice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kristensen, C., Nozue, M., Boucher, Y. et al. Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts. Br J Cancer 74, 533–536 (1996). https://doi.org/10.1038/bjc.1996.397
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.397
- Springer Nature Limited
This article is cited by
-
Combination of intratumoural micellar paclitaxel with radiofrequency ablation: efficacy and toxicity in rodents
European Radiology (2019)
-
Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example
BioDrugs (2013)
-
Intratumoral Drug Delivery with Nanoparticulate Carriers
Pharmaceutical Research (2011)
-
Revolutionizing the treatment of locally advanced extremity soft tissue sarcomas: a review on TNFα-based isolated limb perfusion
European Surgery (2009)
-
Targeted delivery of TNF using NGR-TNF in combination with chemotherapy as an effective and tolerable strategy in a hepatocarcinoma patient
memo - Magazine of European Medical Oncology (2008)